Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies
Psoriasis is a chronic inflammatory skin disease that is currently viewed as a systemic process due to its association with many comorbid conditions. With the appearance of genetically engineered biological drugs (GEBDs), the treatment of psoriasis has undergone significant changes due to their high...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5862 |